IMNN
IMNN
NASDAQ · Biotechnology

Imunon Inc

$1.91
+0.11 (+6.11%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,195.3% upside
Low Target $16.96
Average Target $24.74
High Target $28.19
Current Price $1.91
Current
$1.91
Target
$24.74
$16.96 $24.74 avg $28.19
Scenario Analysis
Bear Case
$16.96
788.0%
Low target
Base Case
$24.74
+1,195.3%
Avg target
Bull Case
$28.19
+1,375.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$11.87
-83.9% from high
52-Week Low
$1.70
+12.4% from low
Target vs 52W High
$24.74
+108.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%